Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+4.73%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$54B
(+2%)
Cap. Flow
+$2.71B
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
972
New
111
Increased
256
Reduced
426
Closed
112
Top Buys
| 1 |
NVIDIA
NVDA
|
$2.63B |
| 2 |
HES
Hess
HES
|
$470M |
| 3 |
Exxon Mobil
XOM
|
$248M |
| 4 |
Hubbell
HUBB
|
$139M |
| 5 |
Costco
COST
|
$124M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$281M |
| 2 |
Emerson Electric
EMR
|
$233M |
| 3 |
AbbVie
ABBV
|
$169M |
| 4 |
Amazon
AMZN
|
$167M |
| 5 |
RB Global
RBA
|
$165M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 10.36% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Equifax
EFX
$29.2B
| $28.8M | 0.05% |
118,600
-62,200
| -34% | -$15.1M |
|
352
Archer Daniels Midland
ADM
$29.6B
| $28.7M | 0.05% |
474,292
-48,900
| -9% | -$2.96M |
|
353
Xcel Energy
XEL
$42.5B
| $28.5M | 0.05% |
532,942
-483,300
| -48% | -$25.8M |
|
354
Align Technology
ALGN
$9.94B
| $28.3M | 0.05% |
117,200
-66,832
| -36% | -$16.1M |
|
|
CNTA
355
Centessa Pharmaceuticals
CNTA
$2.31B
| $28.2M | 0.05% |
3,125,000
+875,000
| +39% | +$7.9M |
|
356
Savara
SVRA
$576M
| $28.2M | 0.05% |
6,987,930
-1,300,000
| -16% | -$5.24M |
|
357
Disc Medicine
IRON
$2.13B
| $27.9M | 0.05% |
618,501
+44,037
| +8% | +$1.98M |
|
358
Equity Residential
EQR
$24.3B
| $27.7M | 0.05% |
399,780
-185,979
| -32% | -$12.9M |
|
359
Targa Resources
TRGP
$35.7B
| $27.4M | 0.05% |
212,700
-6,000
| -3% | -$773K |
|
360
Kroger
KR
$45.3B
| $27.3M | 0.05% |
547,311
-150,450
| -22% | -$7.51M |
|
361
Spyre Therapeutics
SYRE
$1B
| $27.1M | 0.05% |
1,152,411
+47,211
| +4% | +$1.11M |
|
362
AstraZeneca
AZN
$248B
| $27M | 0.05% |
+346,468
| New | +$27M |
|
363
Wave Life Sciences
WVE
$1.53B
| $26.7M | 0.05% |
5,357,719
+156,330
| +3% | +$780K |
|
364
Heron Therapeutics
HRTX
$204M
| $26.6M | 0.05% |
7,600,000
+4,689,989
| +161% | +$16.4M |
|
365
Edison International
EIX
$21.4B
| $26.5M | 0.05% |
369,104
-7,100
| -2% | -$510K |
|
366
ON Semiconductor
ON
$19.8B
| $25.9M | 0.05% |
377,700
-41,400
| -10% | -$2.84M |
|
367
Merit Medical Systems
MMSI
$5.36B
| $25.8M | 0.05% |
300,000
+50,000
| +20% | +$4.3M |
|
368
F5
FFIV
$17.7B
| $25.8M | 0.05% |
149,640
-137,560
| -48% | -$23.7M |
|
369
Idexx Laboratories
IDXX
$51.2B
| $25.8M | 0.05% |
52,878
-3,889
| -7% | -$1.89M |
|
370
TScan Therapeutics
TCRX
$99.9M
| $25.7M | 0.05% |
4,400,000
+500,000
| +13% | +$2.93M |
|
371
Axalta
AXTA
$6.69B
| $25.6M | 0.05% |
750,000
-350,000
| -32% | -$12M |
|
|
INZY
372
DELISTED
Inozyme Pharma
INZY
| $25.6M | 0.05% |
5,728,856
+400,000
| +8% | +$1.78M |
|
|
LB
373
LandBridge Company LLC
LB
$1.38B
| $25.5M | 0.05% |
+1,100,000
| New | +$25.5M |
|
374
Baker Hughes
BKR
$44.7B
| $25.4M | 0.05% |
722,302
+160,600
| +29% | +$5.65M |
|
375
Keurig Dr Pepper
KDP
$39.2B
| $25.3M | 0.05% |
758,200
-263,400
| -26% | -$8.8M |
|